Cancer Stem Cell and Oncology Research

The Company focuses on evolving, manufacturing, and commercialization of therapeutics for cancer patients. Oncology Pharma offers antinuclear antibody that targets areas of necrosis present in solid tumors. Pharma assets in development are linked to cancer. Oncology Pharma offers antinuclear antibody that targets areas of necrosis present in solid tumors. In 2019, the global market for cancer drugs was respected at around 112.73 billion U.S. dollars, according to market research corporation Next MSC. By 2030, this market is forecasted to spread a value of 215 billion U.S. dollars.